Sydney Lupkin
From this contributor
Pharma spending on lobbying skyrocketed in Trump’s first quarter
Eight pharmaceutical companies more than doubled their lobbying spending in the first three months of 2017.
Pharma spending on lobbying skyrocketed in Trump’s first quarter
Health companies gave generously to President Trump’s inauguration
Facing acute risks to their businesses from Washington policymakers, health companies spent more than $2 million to buy access to the incoming Trump administration via candlelight dinners, black-tie balls and other inauguration events.
Health companies gave generously to President Trump’s inauguration
Trump’s choice to run food and drug agency has pharma connections
Scott Gottlieb, nominated to lead the U.S. Food and Drug Administration has deep ties to industry, and has worn many other hats in his career.
Trump’s choice to run food and drug agency has pharma connections
Senators call for investigation into possible abuses of Orphan Drug Act
Building on weeks of mounting pressure to address high prescription drug prices, three influential U.S. senators have asked the government’s accountability arm to probe the orphan drug program for potential misuse.
Senators call for investigation into possible abuses of Orphan Drug Act
Former head of FDA concerned about faster drug approvals
Robert Califf, the just-departed commissioner of the U.S. Food and Drug Administration, offers his take on the Trump administration's plans to speed up drug approvals and dramatically reduce regulations at the agency.
Former head of FDA concerned about faster drug approvals
Explore more from The Transmitter
New findings on Phelan-McDermid syndrome; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 1 September.
New findings on Phelan-McDermid syndrome; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 1 September.
From bench to bot: Why AI-powered writing may not deliver on its promise
Efficiency isn’t everything. The cognitive work of struggling with prose may be a crucial part of what drives scientific progress.
From bench to bot: Why AI-powered writing may not deliver on its promise
Efficiency isn’t everything. The cognitive work of struggling with prose may be a crucial part of what drives scientific progress.
Bringing neuroscience to rural Mexico: In conversation with Mónica López-Hidalgo
By offering education and translating scientific terms into Indigenous languages, López-Hidalgo’s outreach program, Neurociencias Para Todos, provides schoolteachers with tools to bring neuroscience to their communities.
Bringing neuroscience to rural Mexico: In conversation with Mónica López-Hidalgo
By offering education and translating scientific terms into Indigenous languages, López-Hidalgo’s outreach program, Neurociencias Para Todos, provides schoolteachers with tools to bring neuroscience to their communities.